Per-Olof Thuresson

Predicting Life Expectancy for Pirfenidone in Idiopathic Pulmonary Fibrosis

Mark Fisher, Steven D. Nathan, Christian Hill et al. · Journal of Managed Care & Specialty Pharmacy · 2017 · 104 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Cost-effectiveness analysis of neoadjuvant pertuzumab and trastuzumab therapy for locally advanced, inflammatory, or early HER2-positive breast cancer in Canada

C Attard, Amber N. Pepper, S. T. Brown et al. · Journal of Medical Economics · 2014 · 45 citations

Medicine, Oncology, Pharmacoeconomics +17

A Pharmacoeconomic analysis of compliance gains on antipsychotic medications

Joep Damen, Per-Olof Thuresson, Bart Heeg et al. · Applied Health Economics and Health Policy · 2008 · 19 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +16

Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmacies

Amanda McDonell, Urpo Kiiskinen, Danielle Zammit et al. · ClinicoEconomics and Outcomes Research · 2015 · 12 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacology +17